Abstract
Astaxanthin (AXT) is a lipophilic antioxidant and anti-inflammatory natural pigment whose cellular uptake and bioavailability could be improved via liposomal encapsulation. Endothelial cells (EC) line the lumen of all blood vessels and are tasked with multiple roles toward maintaining cardiovascular homeostasis. Endothelial dysfunction is linked to the development of many diseases and is closely interconnected with oxidative stress and vascular inflammation. The uptake of free and liposomal AXT into EC was investigated using Raman and fluorescence microscopies. AXT was either encapsulated in neutral or cationic liposomes. Enhanced uptake and anti-inflammatory effects of liposomal AXT were observed. The anti-inflammatory effects of liposomal AXT were especially prominent in reducing EC lipid unsaturation, lowering numbers of lipid droplets (LDs), and decreasing intercellular adhesion molecule 1 (ICAM-1) overexpression, which is considered a well-known marker for endothelial inflammation. These findings highlight the benefits of AXT liposomal encapsulation on EC and the applicability of Raman imaging to investigate such effects.
Graphical Abstract
Introduction
Liposomal encapsulation has found a wide range of applications including its use to solubilize, increase bioavailability, and improve the stability of several bioactive molecules and natural products [1, 2]. One example of such molecules is astaxanthin (AXT). AXT is a naturally occurring red pigment that has been featured in multiple studies for its antioxidant and anti-inflammatory effects; it has the potential to suppress cancer and can act as an antidiabetic agent [3,4,5,6,7]. Due to its chemical structure, as a carotenoid that consists of a long polyene chain and two terminal rings, AXT is highly lipophilic, which limits its bioavailability and consequently its use as an antioxidant dietary supplement. Liposomal encapsulation is one of the methods shown to improve AXT bioavailability, antioxidant effect, stability, and solubilization. It was reported that both neutral and positively charged liposomes enhance the efficacy of AXT cytoprotective effects in vitro [8,9,10].
Endothelial cells (EC) form a monolayer, lining the lumen of all blood vessels in the body, and participate in multiple activities involved in maintaining cardiovascular homeostasis [11]. EC play an important role in the regulation of blood flow, vascular permeability, thrombosis, angiogenesis, and inflammatory response [12,13,14,15]. Endothelial dysfunction (ED) occurs as a result of the impairment of EC regulatory functions and is linked to the development of many diseases including atherosclerosis, hypertension, liver diseases, diabetes, and even COVID-19 [11, 16,17,18,19,20]. Furthermore, the development of many ED-related pathologies is closely linked to oxidative stress and vascular inflammation [14].
One of the widely used in vitro models of endothelial inflammation is the stimulation of EC by tumor necrosis factor alpha (TNF-α). Upon incubation with TNF-α, EC are activated through the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway [21, 22]. This leads to increased expression of leukocyte adhesion molecules such as intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and cyclooxygenase-2 (COX-2), and alterations in EC lipid content, specifically lipid droplets (LDs) [23, 24]. LDs are lipid-rich cellular organelles that not only act as energy reservoirs but also play an important role in regulating the uptake, metabolism, distribution, and utilization of lipids in cells. Moreover, abnormalities in the content and structure of LDs have been recognized as markers for pathogenesis in cells [25, 26]. For instance, inflamed EC have been shown to contain significantly more LDs of unsaturated lipids compared to control EC [22].
One of the powerful tools used to study cells and their content is Raman microscopy. This method allows clear detection of the subcellular lipids and provides valuable information on their chemical composition in a label-free manner by following the Raman bands associated with lipids in the following spectral regions: 3000–2800 cm−1 (C–H stretching), 1500–1400 cm−1 (CH2 group scissoring), 1300–1250 cm−1 (CH3 group twisting), and 1200–1050 cm−1 (C–C stretching) [25, 27,28,29]. Nevertheless, Raman imaging of biomolecules, including lipids, can be improved using molecular Raman probes (Rp) [25, 30, 31]. We previously introduced astaxanthin as a resonance Raman probe for lipids in EC, showing its potential in signaling subcellular lipidic structures, such as LDs, using relatively lower laser power than required for label-free Raman imaging [26, 32].
AXT absorbs the light in the visible range that coincides with the excitation wavelength of lasers commonly used for cell analysis. AXT fluorescence analysis demonstrates its emission maximum in solution to be around 570 nm [33]; however, the fluorescence emission of AXT depends on its environment, as 600 ± 40 nm was used to analyze AXT cellular content [34, 35]. The Raman spectrum of AXT, when excited by a 532 nm laser, consists of resonantly enhanced bands at ca. 1520, 1159, and 1009 cm−1 [26, 32]. This noticeable signal enhancement allows for the detection of AXT in cells and makes it possible to follow AXT cellular uptake using Raman imaging.
In this study, we aim to follow EC uptake of free and encapsulated AXT using Raman microscopy. Furthermore, we aim to investigate the effects of AXT and AXT-loaded liposomes on inflammatory EC and the resulting alterations in lipid composition. This will shed the light on the potential of bimodal (Raman and fluorescence) imaging to investigate cellular uptake and anti-inflammatory effects of relatively small molecules in free and encapsulated forms.
Materials and methods
Preparation of astaxanthin-loaded neutral and cationic liposomes
Neutral and cationic liposomes were prepared by hydration extrusion method followed by the reconstitution of (3S,3′S)-astaxanthin (AXT, Sigma Aldrich). DPPC (1,2-dipalmitoyl-sn-glycero-3-phosphocholine) lipid was used for the preparation of neutral liposomes and a mixture of DOPE/DOTAP (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine and 1,2-dioleoyl-3-trimethylammonium-propane) was used for cationic liposome preparation. AXT in DMSO was added directly to the liposomes to a final concentration of 10 μM in the liposome solution (molar ratios were as follows: DPPC:AXT = 1:0.007 and DOPE:DOTAP:AXT = 1:0.98:0.036). Chloroform solution of the lipid was dried under nitrogen flow to get a lipid film in a 1.5-mL glass vial and it was kept under high vacuum for 30 min to ensure the complete removal of the solvent. The lipid film was hydrated with 1 mL phosphate buffer saline of pH 7.4 and vortexed for 60 s to get the suspension of lipid in the buffer. This suspension was extruded at least 11 times through a polycarbonate membrane of 100 nm pore size. AXT (10 μM) was reconstituted into the liposomes by 30 min incubation. When AXT was added to the lipid before extrusion, it was observed that the AXT is not getting encapsulated into the liposomes fully as it was clearly visible in the polycarbonate membrane. Different concentrations of AXT ranging from 0.5 to 10 μM were tried with various ratios of lipids before arriving to the optimal ratios (mentioned above) for AXT liposomal encapsulation and cell measurements. Experiments based on 1 μM AXT liposomal concentration (final concentration of 0.33 μM in cell culture media) did not show promising results during the cell-based experiments. Best results were obtained with 10 μM AXT was added to the liposomes after the extrusion and the unbound AXT was removed by dialysis. Any unbound AXT was removed by 5 h of dialysis using pur-A-lyzer kit. DPPC was extruded at 45 °C, above the phase transition temperature.
The hydrodynamic diameters of the samples were measured by dynamic light scattering (DLS) on Malvern Zetasizer Ultra. UV-vis spectra were measured using Jasco V670 UV/Vis spectrophotometer, and fluorescence was measured using a Varian Cary Eclipse Fluorescence spectrophotometer in a quartz cuvette of 1 cm pathlength.
Cell culture and MTS assay
For subsequent Raman measurements, primary human aortic endothelial cells (HAoEC) were seeded on calcium fluoride (CaF2) slides, and for fluorescence imaging, cells were seeded on glass-bottom 96-well plates to reach their optimal confluency after 24 h. HAoEC were cultured in a complete EGM-2MV medium (Lonza, Basel, Switzerland) that had the following supplementations: 10 mM L-glutamine (Gibco Life Technologies), 1 μg/mL hydrocortisone (Sigma Aldrich), 10 mg/mL epidermal growth factor (EGF, Sigma Aldrich), 10% fetal bovine serum (FBS, Gibco Life Technologies), and 1% of antibiotics (streptomycin, penicillin, and fungison, Gibco Life Technologies). All cells were incubated in a 37 °C, 5% CO2/95% air humidified cell culture incubator. Cells were either pre-treated with 10 ng/mL human tumor necrosis factor alpha (TNF-α, Sigma Aldrich) or kept in a fresh medium for 24 h. Afterward, cells (except for the control group) were treated with cell culture media containing 1 μM AXT (Sigma Aldrich), dilution of liposome solutions (to reach the same AXT final concentration, 1 μM) for 30 min, 1 h, 3 h, or 24 h. Cells were then fixed using 2.5% glutaraldehyde for 4 min and kept in phosphate buffer saline (PBS, Gibco Life Technologies) and stored at 4 °C until Raman imaging, or fixed using 4% paraformaldehyde for 10 min and proceeded to staining before fluorescence imaging.
MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] cell viability assay was carried out to assess the cytotoxicity of the used liposomes and free and encapsulated AXT. HAoEC were seeded on plastic-bottom 96-well plates with clear frames and were cultured in a complete EGM-2MV medium (Lonza, Basel, Switzerland) with the same supplementations as previously mentioned. All cells were incubated in a 37 °C, 5% CO2/95% air-humidified cell culture incubator. Cells were either pre-treated with 10 ng/mL TNF-α (Sigma Aldrich) or kept in a fresh medium for 24 h. Afterward, cells (except for the control group) were treated with cell culture media containing 1 μM AXT (Sigma Aldrich), dilution of liposome solutions (to reach the same AXT final concentration, 1 μM), or empty (not containing AXT) liposomes for 24 h. After the treatment, cells were washed, and according to the manufacturer’s instructions, 20 μL of MTS (CellTiter 96 AQueous One Solution Cell Proliferation Assay, Promega, USA) labeling reagent was added to each well, and plates were incubated at 37 °C for 2 h. Following MTS incubation, the absorbance of the samples was measured using Spark 10M microplate reader (Tecan, Switzerland) at 490 nm.
No significant effect on the cells’ viability was observed in the groups of cells treated with AXT, neutral or cationic liposomes or AXT encapsulated in either when used in the same concentrations or maximum incubation time (24 h) used in the manuscript (Online Resource, Fig. S1). Therefore, it was concluded that the used treatments were not cytotoxic at the conditions (concentrations and incubation times) used in the study.
Raman imaging
Raman imaging was carried out using a WITec alpha 300 confocal Raman imaging system (WITec GmbH, Ulm, Germany) equipped with an ultra-high-throughput screening (UHTS) 300 spectrograph, a charge-coupled device (CCD) detector (Andor, DU401A-BV-352), and a × 60 water immersion objective (Nikon Fluor, NA = 1.0). An air-cooled solid-state laser with an excitation wavelength of 532 nm was used to excite the samples. Each measurement was done twice; once with a laser power at the cell samples of 3 mW (low laser power) and once with a laser power of 30 mW (high laser power). Low laser power measurements were done using a 0.5 s integration time and high laser power measurements were done using a 0.2 s integration time; a 0.5 μm step size was used for both.
Staining and fluorescence imaging
Fixed HAoEC were permeabilized using 0.1% Triton-X 100 solution in PBS for 5 min, washed and blocked using 5% normal goat serum. Afterward, samples were incubated with ICAM-1 Monoclonal Antibody (Cat. No: MA5407, Invitrogen) (1.0 mg/mL, diluted 1:250) at 4 °C overnight. Then, they were washed with PBS and incubated with Alexa Fluor 647 goat-anti-mouse (Jackson Immunoresearch Laboratories, 1:300) in the dark at room temperature for 30 min, and then washed with PBS. BODIPY 493/503 (Invitrogen, 4 μg/mL) was used according to the manufacturer’s instructions to stain neutral lipids. Finally, Hoechst 33342 (Cat. No: H3570, Thermo Scientific) (10 mg/mL, diluted 1:1000) was used to stain cell nuclei for 10 min in the dark. After washing, cells were kept in PBS and imaged immediately. The confocal quantitative image cytometer (CQ1, Yokogawa) was used for fluorescence imaging.
Data analysis
Raman spectra obtained from all samples were processed by a routine cosmic ray removal and were baseline corrected using auto-polynomial of degree 3 (WITec Project Plus software). Cluster analysis (CA) was performed with the k-means method (k-means cluster analysis, KMCA) using the Manhattan distance (WITec Project Plus software) utilized to obtain averaged spectra of the lipids classes. Origin Pro 2022 was used for normalizing and presenting the spectra.
ImageJ (National Institutes of Health; http://rsbweb.nih.gov/ij/) and Columbus Image Data Storage and Analysis System (Perkin Elmer) were used for the processing of the fluorescence images. The total number of cell nuclei (based on Hoechst staining), the number of lipid droplets (LDs), and the average fluorescence intensity of ICAM-1 (calculated using Columbus software from the total area of the cells) were calculated. To determine the statistical significance, a two-sample t-test was used (Origin Pro, 2022).
Results and discussion
AXT-loaded liposomes characterized by Raman spectroscopy
Two different types of large unilamellar vesicles (LUVs) of diameter 100 nm were used: neutral liposomes of DPPC lipid (1.3623 mM in PBS), and cationic liposomes comprised of DOTAP (0.2719 mM) and DOPE (0.27726 mM in PBS). Both types of LUVs were loaded with AXT at the same concentration (10 μM). It has been previously shown that there is a slight shift in the C=C stretching Raman band of AXT from ca. 1516 cm−1 for the solid state to ca. 1520 cm−1 for AXT dissolved in lipids [26]. The Raman spectra in Fig. 1A demonstrate a similar shift in the mentioned band between AXT powder and when it is encapsulated in DPPC liposomes. As shown in Fig. 1B, AXT absorbs light in the visible range coinciding with the 532 nm laser, which is usually used for cell measurements, and thus offers pre-resonance enhancement noticeable in the Raman spectrum of AXT. Specifically, resonantly enhanced Raman bands of AXT are observed at ca. 1009, 1159, and 1520 cm−1 corresponding to CH3 group wagging, C–C stretching, and C=C stretching vibrations, respectively.
Time-dependent uptake of AXT and AXT-loaded liposomes by EC
After EC incubation with AXT and AXT-loaded neutral or cationic liposomes using different incubation times, Raman spectra from AXT within the cells were visible only after 30 min of incubation. As expected, AXT was present in the cytoplasm of cells, specifically in the lipid-rich cellular organelles, i.e., LDs and endoplasmic reticulum (ER). As shown in Fig. 2, AXT accumulation in cellular lipids was time dependent. At shorter incubation times (30 and 60 min), AXT was found in lipid-rich areas in the cytoplasm but did not colocalize with all LDs of the cell. Starting from 3 h of incubation, AXT distribution demonstrates a clear colocalization with lipids in EC, determined by comparing the Raman maps of AXT (integration of the Raman spectra around 1520 cm−1) and lipids (integration of the Raman spectra around 2865 cm−1).
Subtle changes in the uptake and distribution of free AXT compared to that of encapsulated AXT were identifiable. For instance, it was noticeable that positively charged liposomes showed an enhanced uptake by HAoEC, demonstrated by a higher intensity of AXT marker bands, compared to neutral liposomes and free AXT. A similar effect has been previously reported in human corneal epithelial cells (HCECs) [9].
Effect of liposomal encapsulation on AXT anti-inflammatory activity in EC
Both the number and the composition of LDs in EC have been previously shown to change when EC are activated using TNF-α [22]. This same effect can be seen in Fig. 3A; when control HAoEC is compared with TNF-α pre-treated group, a higher number of LDs are observed. Moreover, LDs in the TNF-α pre-treated group consist mostly of unsaturated lipids, evidenced by a higher intensity of the Raman band at ca. 3015 cm−1 (associated with the stretching modes of =C–H), which is characteristic of unsaturated lipids.
Following EC activation, cells were incubated with AXT, AXT-loaded neutral liposomes, or AXT-loaded cationic liposomes for 1, 3, or 24 h. Compared to the control, cells that were pre-incubated with TNF-α (10 ng/mL) for 24 h contained more LDs rich in unsaturated lipids, as shown in the third row (Fig. 3A). The prevalence of unsaturated LDs in inflamed cells that were later treated with AXT, either free or encapsulated, was shown to decrease, highlighting the effect of AXT in both free and encapsulated forms to attenuate the impact of TNF-α pre-treatment on EC lipid composition. Furthermore, encapsulated AXT in neutral or cationic liposomes showed a stronger effect on EC lipid unsaturation compared to free AXT. K-means cluster analysis (KMCA) was utilized to extract the spectra of the class of lipids in each cell. By comparing the averaged lipid spectra of each group, shown in Fig. 3B, a twofold increase in the intensity of the unsaturated lipids band at ca. 3015 cm−1 in the group of cells subjected to TNF-α pre-treatment was observed. This band was shown to decrease following incubation with AXT and AXT-loaded liposomes, showcasing the capability of Raman imaging to detect AXT accumulation and the uptake of free and encapsulated AXT. Moreover, the data indicated changes in the lipid composition of the EC in the cases of inflammation and anti-inflammatory treatment with free or encapsulated AXT.
To quantify the anti-inflammatory effect and changes in LD content induced in activated EC by AXT, AXT-loaded neutral and cationic liposomes, fluorescence imaging was utilized as a reference method. Expression of ICAM-1, a well-known marker of EC inflammation, was compared among the different groups. A significant ICAM-1 overexpression was seen following activation with TNF-α compared to control, reflected in the relative ICAM-1 expression of the TNF-α pre-treated cells which was 119.2 ± 4.6% of the control (Fig. 4A). This overexpression was significantly decreased to the control level when cells were treated with free or encapsulated AXT. Moreover, this anti-inflammatory effect is stronger in cells treated with AXT-loaded liposomes, as the relative ICAM-1 expressions of activated EC treated with free AXT, AXT in neutral liposomes, and AXT in cationic liposomes were 106.6 ± 2.4%, 99.9 ± 1.8%, and 100.5 ± 2.6% of the control, respectively.
A significant increase in the number of LDs per cell in the group of cells incubated with TNF-α was observed (Fig. 4B). While the number of LDs was decreased after treatment with free AXT, this effect was not significant. On the other hand, when activated EC were treated with encapsulated AXT in neutral or cationic liposomes, the number of LDs per cell decreased by 22% and 24%, respectively, compared to TNF-α incubated cells that were not subjected to anti-inflammatory treatment.
The results of two complementary methods, Raman and fluorescence microscopies, clearly indicate that the anti-inflammatory effects of AXT on EC can be enhanced by encapsulating AXT both in neutral and positively charged liposomes, specifically in terms of decreasing lipid unsaturation and lowering ICAM-1 overexpression. Moreover, while free AXT does not significantly decrease the number of LDs in inflamed EC, encapsulated AXT lowered the numbers of LDs in inflamed EC significantly.
Conclusions
This study examined the uptake of AXT encapsulated in neutral and positively charged liposomes by Raman microscopy with the support of fluorescence microscopy. Raman imaging provided insight into the uptake of free and encapsulated AXT by EC in healthy and inflamed states. EC incubated with TNF-α showed alterations in LD composition toward more unsaturated lipids, a feature previously linked to EC inflammation. Moreover, the anti-inflammatory effect of AXT-loaded liposomes has been demonstrated by Raman imaging, highlighting a decrease in the unsaturated lipids content in activated EC subjected to anti-inflammatory treatment.
Similarly, fluorescence imaging showed a significant anti-inflammatory effect of AXT-loaded neutral and cationic liposomes on activated EC, manifested by a substantial decrease in ICAM-1 overexpression and the number of LDs per cell. While free AXT treatment resulted in a significant decrease of ICAM-1 expression, it did not have as significant an effect on LDs as encapsulated AXT.
It is worth noting that it is challenging to accurately quantify the intracellular AXT content using the presented Raman microscopy–based method due to the resonance effect of AXT. Nevertheless, semi-quantitative information on the AXT distribution and comparative assessment in different conditions can be acquired. The presented method is also rather time consuming due to the longer image acquisition time and the need to image each sample twice (once with lower and once with higher laser powers) because of AXT sensitivity to higher laser power. On the other hand, the use of Raman imaging to analyze AXT uptake and effects on EC lipids could be done in a label-free manner, eliminating the undesirable effects of dyes used for fluorescence-based detection (such as the risk of photobleaching, the biological effects of the dyes affecting the results, the need for the additional steps of blocking, staining, and washing). Furthermore, the utilization of techniques such as stimulated Raman scattering (SRS) microscopy would allow much faster detection of cellular uptake and effects of various molecules in future studies.
In conclusion, encapsulating AXT in neutral or positively charged liposomes enhanced AXT’s anti-inflammatory effects, in terms of decreasing EC lipid unsaturation and ICAM-1 overexpression, and reduced the number of LDs in inflamed EC, while free AXT did not significantly have an effect decreasing the number of LDs. Raman imaging provided information on AXT uptake and accumulation and changes in EC lipid composition, whereas fluorescence imaging allowed quantification of the anti-inflammatory effects of encapsulated AXT.
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Akbarzadeh A, Rezaei-Sadabady R, Davaran S et al (2013) Liposome: classification, preparation, and applications. Nanoscale Res Lett 8:102. https://doi.org/10.1186/1556-276X-8-102
Trif M, Craciunescu O (2015) Liposome as efficient system for intracellular delivery of bioactive molecules. In: Nanotechnology and functional foods. John Wiley & Sons, Ltd, Chichester, UK, pp 191–213
Pereira C, Souza A, Vasconcelos A et al (2020) Antioxidant and anti-inflammatory mechanisms of action of astaxanthin in cardiovascular diseases (Review). Int J Mol Med 47:37–48. https://doi.org/10.3892/ijmm.2020.4783
Rao AR, Sindhuja HN, Dharmesh SM et al (2013) Effective inhibition of skin cancer, tyrosinase, and antioxidative properties by astaxanthin and astaxanthin esters from the green alga Haematococcus pluvialis. J Agric Food Chem 61:3842–3851. https://doi.org/10.1021/jf304609j
Visioli F, Artaria C (2017) Astaxanthin in cardiovascular health and disease: mechanisms of action, therapeutic merits, and knowledge gaps. Food Funct 8:39–63. https://doi.org/10.1039/C6FO01721E
Kim H-Y, Kim Y-M, Hong S (2019) Astaxanthin suppresses the metastasis of colon cancer by inhibiting the MYC-mediated downregulation of microRNA-29a-3p and microRNA-200a. Sci Rep 9:9457. https://doi.org/10.1038/s41598-019-45924-3
Ni Y, Nagashimada M, Zhuge F et al (2015) Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: a comparison with vitamin E. Sci Rep 5:17192. https://doi.org/10.1038/srep17192
Sangsuriyawong A, Limpawattana M, Siriwan D, Klaypradit W (2019) Properties and bioavailability assessment of shrimp astaxanthin loaded liposomes. Food Sci Biotechnol 28:529–537. https://doi.org/10.1007/s10068-018-0495-x
Shimokawa T, Yoshida M, Fukuta T et al (2019) Efficacy of high-affinity liposomal astaxanthin on up-regulation of age-related markers induced by oxidative stress in human corneal epithelial cells. J Clin Biochem Nutr 64:27–35. https://doi.org/10.3164/jcbn.18-27
Chiu C-H, Chang C-C, Lin S-T et al (2016) Improved hepatoprotective effect of liposome-encapsulated astaxanthin in lipopolysaccharide-induced acute hepatotoxicity. Int J Mol Sci 17:1128. https://doi.org/10.3390/ijms17071128
Rajendran P, Rengarajan T, Thangavel J et al (2013) The vascular endothelium and human diseases. Int J Biol Sci 9:1057–1069. https://doi.org/10.7150/ijbs.7502
Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction. circulation 115:1285–1295. https://doi.org/10.1161/CIRCULATIONAHA.106.652859
Galley HF, Webster NR (2004) Physiology of the endothelium. Br J Anaesth 93:105–113. https://doi.org/10.1093/bja/aeh163
Daiber A, Chlopicki S (2020) Revisiting pharmacology of oxidative stress and endothelial dysfunction in cardiovascular disease: evidence for redox-based therapies. Free Radic Biol Med 157:15–37. https://doi.org/10.1016/j.freeradbiomed.2020.02.026
Walczak M, Suraj J, Kus K et al (2015) Towards a comprehensive endothelial biomarkers profiling and endothelium-guided pharmacotherapy. Pharmacol Reports 67:771–777. https://doi.org/10.1016/j.pharep.2015.06.008
Maslak E, Gregorius A, Chlopicki S (2015) Liver sinusoidal endothelial cells (LSECs) function and NAFLD; NO-based therapy targeted to the liver. Pharmacol Reports 67:689–694. https://doi.org/10.1016/j.pharep.2015.04.010
Smeda M, Przyborowski K, Stojak M, Chlopicki S (2020) The endothelial barrier and cancer metastasis: does the protective facet of platelet function matter? Biochem Pharmacol 176:113886. https://doi.org/10.1016/j.bcp.2020.113886
Smeda M, Chlopicki S (2020) Endothelial barrier integrity in COVID-19-dependent hyperinflammation: does the protective facet of platelet function matter? Cardiovasc Res 116:e118–e121. https://doi.org/10.1093/cvr/cvaa190
Huertas A, Montani D, Savale L et al (2020) Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? Eur Respir J 56:2001634. https://doi.org/10.1183/13993003.01634-2020
Ruhl L, Pink I, Kühne JF et al (2021) Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks. Signal Transduct Target Ther 6:418. https://doi.org/10.1038/s41392-021-00819-6
van Hinsbergh VWM (2012) Endothelium--role in regulation of coagulation and inflammation. Semin Immunopathol 34:93–106. https://doi.org/10.1007/s00281-011-0285-5
Czamara K, Majzner K, Selmi A et al (2017) Unsaturated lipid bodies as a hallmark of inflammation studied by Raman 2D and 3D microscopy. Sci Rep 7:40889. https://doi.org/10.1038/srep40889
Jung HS, Shimizu-Albergine M, Shen X et al (2020) TNF-α induces acyl-CoA synthetase 3 to promote lipid droplet formation in human endothelial cells. J Lipid Res 61:33–44. https://doi.org/10.1194/jlr.RA119000256
Jarc E, Petan T (2020) A twist of FATe: lipid droplets and inflammatory lipid mediators. Biochimie 169:69–87. https://doi.org/10.1016/j.biochi.2019.11.016
Adamczyk A, Matuszyk E, Radwan B et al (2021) Toward Raman subcellular imaging of endothelial dysfunction. J Med Chem 64:4396–4409. https://doi.org/10.1021/acs.jmedchem.1c00051
Radwan B, Adamczyk A, Tott S et al (2020) Labeled vs. label-free Raman imaging of lipids in endothelial cells of various origins. Molecules 25:5752. https://doi.org/10.3390/molecules25235752
Baranska M, Kaczor A, Malek K et al (2015) Raman microscopy as a novel tool to detect endothelial dysfunction. Pharmacol Reports 67:736–743. https://doi.org/10.1016/j.pharep.2015.03.015
Czamara K, Majzner K, Pacia MZ et al (2015) Raman spectroscopy of lipids: a review. J Raman Spectrosc 46:4–20. https://doi.org/10.1002/jrs.4607
Majzner K, Kochan K, Kachamakova-Trojanowska N et al (2014) Raman imaging providing insights into chemical composition of lipid droplets of different size and origin: in hepatocytes and endothelium. Anal Chem 86:6666–6674. https://doi.org/10.1021/ac501395g
Matuszyk E, Adamczyk A, Radwan B et al (2021) Multiplex Raman imaging of organelles in endothelial cells. Spectrochim Acta Part A Mol Biomol Spectrosc 255:119658. https://doi.org/10.1016/j.saa.2021.119658
Radwan B, Rocchetti S, Matuszyk E et al (2022) EdU sensing: the Raman way of following endothelial cell proliferation in vitro and ex vivo. Biosens Bioelectron 216:114624. https://doi.org/10.1016/j.bios.2022.114624
Czamara K, Adamczyk A, Stojak M et al (2021) Astaxanthin as a new Raman probe for biosensing of specific subcellular lipidic structures: can we detect lipids in cells under resonance conditions? Cell Mol Life Sci 78:3477–3484. https://doi.org/10.1007/s00018-020-03718-1
Ukibe K, Katsuragi T, Tani Y, Takagi H (2008) Efficient screening for astaxanthin-overproducing mutants of the yeast Xanthophyllomyces dendrorhous by flow cytometry. FEMS Microbiol Lett 286:241–248. https://doi.org/10.1111/j.1574-6968.2008.01278.x
Chen J, Wei D, Pohnert G (2017) Rapid estimation of astaxanthin and the carotenoid-to-chlorophyll ratio in the green microalga Chromochloris zofingiensis using flow cytometry. Mar Drugs 15:231. https://doi.org/10.3390/md15070231
Wayama M, Ota S, Matsuura H et al (2013) Three-dimensional ultrastructural study of oil and astaxanthin accumulation during encystment in the green alga Haematococcus pluvialis. PLoS One 8:e53618. https://doi.org/10.1371/journal.pone.0053618
Acknowledgements
This study was supported by the European Union’s Horizon 2020 Research and Innovation Programme under Marie Sklodowska-Curie [Grant Agreement 813920 (LogicLab ITN)], and by a grant from the National Science Center Poland (NCN) (Opus15 no. UMO-2018/29/B/ST4/00335). The authors are grateful to Prof. Stefan Chlopicki for his continuous and valuable support in his capacity as the Director of JCET. The authors extend their thanks to MSc Renata Budzynska (JCET) for cell culture maintenance and Adrianna Wisłocka-Orłowska for technical support.
Author information
Authors and Affiliations
Contributions
BR: planning, cell treatment, Raman and fluorescence measurements, preparing figures, and writing; AP: liposome preparation and DLS measurements; SR: fluorescence imaging; EM: supervision of the initial work; TK: supervision of AP and supervision of BR secondment; MB: financing, conceptualization, supervision, planning, and writing.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
ESM 1
(DOCX 27 kb)
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Radwan, B., Prabhakaran, A., Rocchetti, S. et al. Uptake and anti-inflammatory effects of liposomal astaxanthin on endothelial cells tracked by Raman and fluorescence imaging. Microchim Acta 190, 332 (2023). https://doi.org/10.1007/s00604-023-05888-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00604-023-05888-8